PURPOSE: Lynch syndrome (LS) is a common inherited predisposition to colorectal cancer (CRC). In LS patients, CRC is predominantly located in the right colon, as opposed to sporadic CRC, which usually affects the left colon or rectum. Previous studies have demonstrated a clear distinction in gene expression between sporadic CRC and normal colon at different locations in the colorectum. However, little is known about LS gene expression profiles in different areas of the colorectum. Here, we compared the protein expression profiles for normal colorectal samples among different locations as well as between adenomas and matched normal tissue in LS. METHODS: Protein from 33 tissue samples (27 normal tissues and 6 adenomas) from 9 patients with LS was extracted for reverse-phase protein array (RPPA) analysis. The antibody panel used for RPPA included 109 key proteins involved in various cancer-related pathways. Cluster 3.0 was used for unsupervised and supervised clustering analysis. RESULTS: IGF1R and COL6A1 were expressed significantly differently between the normal right and normal left colon (q < 0.05); FN1, COL6A1, and IGF1R were expressed significantly differently between the normal right colon and normal rectum (q < 0.05). In the adenomas and matched normal tissue, PEA-15 was the only protein with significantly different expression (q < 0.05). CONCLUSION: We found differences in protein expression between normal tissues from the right colon, left colon, and rectum as well as between adenomas and matched normal tissue. However, those differences should be further confirmed in a larger sample size.
PURPOSE:Lynch syndrome (LS) is a common inherited predisposition to colorectal cancer (CRC). In LS patients, CRC is predominantly located in the right colon, as opposed to sporadic CRC, which usually affects the left colon or rectum. Previous studies have demonstrated a clear distinction in gene expression between sporadic CRC and normal colon at different locations in the colorectum. However, little is known about LS gene expression profiles in different areas of the colorectum. Here, we compared the protein expression profiles for normal colorectal samples among different locations as well as between adenomas and matched normal tissue in LS. METHODS: Protein from 33 tissue samples (27 normal tissues and 6 adenomas) from 9 patients with LS was extracted for reverse-phase protein array (RPPA) analysis. The antibody panel used for RPPA included 109 key proteins involved in various cancer-related pathways. Cluster 3.0 was used for unsupervised and supervised clustering analysis. RESULTS:IGF1R and COL6A1 were expressed significantly differently between the normal right and normal left colon (q < 0.05); FN1, COL6A1, and IGF1R were expressed significantly differently between the normal right colon and normal rectum (q < 0.05). In the adenomas and matched normal tissue, PEA-15 was the only protein with significantly different expression (q < 0.05). CONCLUSION: We found differences in protein expression between normal tissues from the right colon, left colon, and rectum as well as between adenomas and matched normal tissue. However, those differences should be further confirmed in a larger sample size.
Authors: Miguel Angel Ramírez-Ramírez; Sergio Sobrino-Cossío; José Guillermo de la Mora-Levy; Angélica Hernández-Guerrero; Verónica de Jesús Macedo-Reyes; Héctor Aquiles Maldonado-Martínez; Juan Octavio Alonso-Larraga; Mauro Eduardo Ramírez-Solis Journal: J Gastrointest Cancer Date: 2012-06
Authors: Mala Pande; Chongjuan Wei; Jinyun Chen; Christopher I Amos; Patrick M Lynch; Karen H Lu; Laura A Lucio; Stephanie G Boyd-Rogers; Sarah A Bannon; Maureen E Mork; Marsha L Frazier Journal: Fam Cancer Date: 2012-09 Impact factor: 2.375
Authors: Oleg K Glebov; Luz M Rodriguez; Kenneth Nakahara; Jean Jenkins; Janet Cliatt; Casey-Jo Humbyrd; John DeNobile; Peter Soballe; Richard Simon; George Wright; Patrick Lynch; Sherri Patterson; Henry Lynch; Steven Gallinger; Aby Buchbinder; Gary Gordon; Ernest Hawk; Ilan R Kirsch Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-08 Impact factor: 4.254
Authors: C Hao; F Beguinot; G Condorelli; A Trencia; E G Van Meir; V W Yong; I F Parney; W H Roa; K C Petruk Journal: Cancer Res Date: 2001-02-01 Impact factor: 12.701
Authors: Maja Ludvigsen; Louise Thorlacius-Ussing; Henrik Vorum; Mogens Tornby Stender; Ole Thorlacius-Ussing; Bent Honoré Journal: Curr Issues Mol Biol Date: 2021-09-02 Impact factor: 2.976